Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secretory phospholipase A2 (sPLA2) is an enzyme that catalyzes the hydrolysis of the sn-2 ester bond in glycerophospholipids, releasing free fatty acids and lysophospholipids. It plays a crucial role in various biological processes, including inflammation, host immunity, and lipid signaling. Dysregulation of sPLA2 is linked to inflammatory diseases.
Catalyzes hydrolysis at the sn-2 position of membrane phospholipids to generate free fatty acids (often arachidonic acid) and lysophospholipid products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secretory Phospholipase A2 (sPLA2).